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It might seem excessively nationalistic to name a journal
supplement after a specific country (e.g., Swiss supple-
ment, Italian supplement, Indian supplement etc.). How-
ever, the production of a national supplement of the
European Spine Journal allows the editors to present to the
readers a particularly unique characteristic or strength of
that community which brings a stronger personal identity
to the journal, while providing new perspective.
Switzerland’s clinicians and scientists have been true
pioneers in the orthopaedic and neuroscience fields. With
the establishment of the AO Foundation over 50 years ago,
and the subsequent growth of the foundation’s spine
activities, support for research, development and teaching
has been a long-standing priority. Switzerland is a nation of
inventors, with a proven track record of innovation and
translation of ideas to clinical practice. The Swiss Med-
Tech industry has no parallel in Europe, in terms of per
capita investment in R & D and exports of medical devices.
In the academic environment, there is some pride in
seeing one’s institution among the elite in rankings. This
applies also to the editor’s respective universities in the
field of engineering and life sciences, with the ETH in
Zurich and the University of Lausanne being in the 15th
and 41st place, respectively (Times higher education
ranking for 2011–12). It has even less to do with ethnic
origins, since in a country such as Switzerland, a large
number of nationalities make up the body of researchers
and this is mirrored in the current composition of the
supplement’s authorship. Indeed, for all the reasons above,
Switzerland is one of the few countries experiencing ‘‘brain
gain’’, with an immigrant population approaching 20 %,
with a large proportion in highly skilled professions.
Furthermore, the European Spine Journal and the Spine
Society of Europe have been intrinsically linked to Swit-
zerland for many years now. The editorial office of the
journal and the de facto administrative office of the society
are both located in Switzerland. Professor Max Aebi has
founded and guided the journal, as editor-in-chief, since its
inception. Swiss scientists and clinicians are well repre-
sented on the editorial board of the journal and in the
membership roster of the society.
Historically, Swiss authors have submitted a large
number of manuscripts to the journal, in relation to the
country’s population, and these papers are traditionally of a
very high quality. Swiss authors are well represented as
winners of prestigious spinal sciences awards, including
the GRAMMER award and the scientific awards of the
Spine Society of Europe. On this basis, we are confident
that the selection of papers in this supplement will offer
something for every reader, and represents a high standard
of clinical or scientific work.
Inevitably, some papers have originated from the edi-
tors’ own collaborators. All papers went through the same
robust blinded review process as any paper normally sub-
mitted to the European Spine Journal and this included
outsourcing of editorial decisions, when required, to avoid
any bias.
In the clinical part of the supplement, the reader can find
papers on vertebroplasty, spondylolisthesis, pain screening
questionnaires and other spine-related outcome measures,
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scoliosis surgery, spinal stenosis imaging and disc arthro-
plasty. In the basic science section, the reader will find
studies on the in situ biomechanics of the scoliotic spine,
the degenerative changes of the disc across all spinal lev-
els, on the potential importance of notochordal cells, a
unique perspective on anti-inflammatory agents and several
papers exploring the interaction between native spinal tis-
sue and novel biomaterials.
We hope, with this supplement, to give the reader an
informative snapshot of the Swiss clinical and basic sci-
ence fields and to stimulate further discussion and
interaction.
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